Hostname: page-component-745bb68f8f-cphqk Total loading time: 0 Render date: 2025-01-26T01:49:41.922Z Has data issue: false hasContentIssue false
  • English
  • Français

Biological markers of depression1

Published online by Cambridge University Press:  09 July 2009

P. J. Cowen  and
A. J. Wood
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Editorial
Information
Psychological Medicine , Volume 21 , Issue 4 , November 1991 , pp. 831 - 836
Copyright
Copyright © Cambridge University Press 1991

References

Abou-Saleh, M. T. (1988). How useful is a dexamethasone suppression test? Current Opinion in Psychiatry 1, 60–65.CrossRefGoogle Scholar
Akagawa, K., Watanabe, M. & Tsukada, Y. (1980). Activity of Na-KATPase in manic patients. Journal of Neurochemistry 35, 258–260.CrossRefGoogle Scholar
Amsterdam, J. D., Maislin, G., Winokur, A., Kling, M. & Gold, P. (1987). Pituitary and adrenocortical responses to the ovine corticotropin releasing hormone in depressed patients and healthy volunteers. Archives of General Psychiatry 44, 775–781.CrossRefGoogle Scholar
Arora, R. C. & Meltzer, H. Y. (1989 a). Serotonergic measures in the brains of suicide victims: 5-HT2 binding sites in frontal cortex of suicide victims and control subjects. American Journal of Psychiatry 146, 730–736.Google ScholarPubMed
Arora, R. C. & Meltzer, H. Y. (1989 b). Increased serotonin (5-HT2) receptor binding as measured by 3H-lysergic acid diethylamide (3H-LSD) in the blood platelets of depressed patients. Life Sciences 44, 725–734.CrossRefGoogle ScholarPubMed
Banki, C. M., Bissette, G., Arato, M., O'Connor, I. & NemerofT, C. B. (1987). CSF corticotropin-releasing factor-like immunoreactivity in depression and schizophrenia. American Journal Psychiatry 144, 873–877.Google ScholarPubMed
Berger, M., Riemann, D., Höchli, D. & Spiegel, R. L. (1989). The cholinergic rapid eye movement sleep induction test with RS-86. Archives of General Psychiatry 46, 421–426.CrossRefGoogle ScholarPubMed
Braddock, L. E. (1986). Dexamethasone suppression test: fact or artefact? British Journal of Psychiatry 148, 363–371.CrossRefGoogle ScholarPubMed
Briley, M. S. R., Langer, S. Z., Raisman, R., Sechter, D. & Zarifian, E. (1980). Tritiated imipramine binding sites are decreased in the platelets of untreated depressed patients. Science 209, 303–305.CrossRefGoogle ScholarPubMed
Campbell, S. S. & Gillin, J. C. (1987). Sleep measures in depression – how sensitive – how specific? Psychiatric Annals 17, 647–653.CrossRefGoogle Scholar
Charney, D. S. & Heninger, G. R. (1986). Serotonin function in panic disorders. Archives of General Psychiatry 43, 1059–1065.CrossRefGoogle ScholarPubMed
Charney, D. S., Goodman, W. K., Price, L. H., Woods, S. W., Rosmussen, S. A. & Heninger, G. R. (1988). Serotonin function in obsessive compulsive disorder: a comparison of the effects of tryptophan and m-chlorophenyl-piperazine in patients and healthy subjects. Archives of General Psychiatry 45, 177–185.CrossRefGoogle Scholar
Cheetham, S. C., Crompton, M. R., Katona, C. L. E. & Horton, R. W. (1988). Brain 5-HT2 receptor binding in depressed suicide victims. Brain Research 443, 272–280.CrossRefGoogle ScholarPubMed
Corn, T., Thompson, C. & Checkley, S. A. (1984). Effects of desipramine treatment upon central adrenoceptor function in normal subjects. British Journal of Psychiatry 145, 139–145.CrossRefGoogle ScholarPubMed
Cowen, P. J. (1989). Biological markers in depression. Current Opinion in Psychiatry 2, 106–109.CrossRefGoogle Scholar
Cowen, P. J. & Anderson, I. M. (1991). Abnormal 5-HT neuroendocrine function in depression: association or artefact? In 5-Hydroxytryptamine in Mental Illness: A Spectrum of Ideas (ed. Sandier, M., Coppen, A. and Harnett, S.), pp. 124–142. Oxford University Press: Oxford.Google Scholar
Cowen, P. J. & Charig, E. M. (1987). Neuroendocrine responses to intravenous tryptophan in major depression. Archives of General Psychiatry 44, 958–966.CrossRefGoogle ScholarPubMed
Cowen, P. J., Geaney, D. P., Schächter, M., Green, A. R. & Elliott, J. M. (1986). Desipramine treatment in normal subjects: effects on neuroendocrine responses to tryptophan and on platelet serotonin (5-HT)-related receptors. Archives of General Psychiatry 43, 61–67.CrossRefGoogle ScholarPubMed
Cowen, P. J., Charig, E. M., Fraser, S. & Elliott, J. M. (1987). 5-HT receptor binding during depressive illness and tricyclic antidepressant treatment. Journal of Affective Disorders 13, 45–50.CrossRefGoogle ScholarPubMed
Deakin, J. F. W., Pennell, I., Upadhyaya, A. J. & Lofthouse, R. (1990). A neuroendocrine study of 5-HT function in depression: evidence for biological mechanisms of endogenous and psychosocial causation. Psychopharmacology 101, 85–92.CrossRefGoogle ScholarPubMed
De Paermentier, F., Cheetham, S. C., Crompton, S. R. & Horton, R. (1990). Brain β-adrenoceptor binding sites in antidepressant-free depressed suicide victims. Brain Research 25, 71–72.CrossRefGoogle Scholar
Elliott, J. M. (1984). Platelet receptor binding studies in affective disorder. Journal of Affective Disorder 8, 219–239.CrossRefGoogle Scholar
Famborough, D. M. (1988). The sodium pump becomes a family. Trends in Neurosciences 7, 325–328.CrossRefGoogle Scholar
Gershon, E. S., Merril, C. R., Goldin, L. R., Delisi, L. E., Berrettini, W. H. & Nurnberger, J. I. (1987). The role of molecular genetics in psychiatry. Biological Psychiatry 22, 1388–1405.CrossRefGoogle ScholarPubMed
Giles, D. E., Biggs, M. M., Rush, A. J. & Roffwarg, H. P. (1988). Risk factors in families of unipolar depression. I. Psychiatric illness and reduced REM latency. Journal of Affective Disorders 14, 51–60.CrossRefGoogle ScholarPubMed
Halpern, J. P., Brown, R. P., Sweeney, J. A., Kocsis, J. H., Peters, A. & Mann, J. J. (1988). Blunted β-adrenergic responsivity of peripheral blood mononuclear cells in endogenous depression. Archives of General Psychiatry 45, 241–246.CrossRefGoogle Scholar
Hokin-Neaverson, M., Spiegel, D. A. & Lewis, W. C. (1974). Deficiency of erythrocyte sodium pump activity in bipolar manic depressive psychosis. Life Sciences 15, 1739–1748.CrossRefGoogle ScholarPubMed
Hokin-Neaverson, M., Burckhardt, W. & Jefferson, J. W. (1976). Increased erythrocyte Na+ pump and Na-KATPase activity during lithium therapy. Research Communications in Pathology and Pharmacology 14, 117–126.Google Scholar
Katona, C. L. E., Theodorou, A. E. & Horton, R. W. (1987). Alpha-2-adrenoceptors in depression. Psychiatric Developments 5, 129–150.Google ScholarPubMed
Koyama, T. & Meltzer, H. Y. (1986). A biochemical and neuroendocrine crine study of the serotonergic system in depression. In New Results of Depression Research (ed. Hippius, H.), pp. 169–188. Springer-Verlag: Berlin.CrossRefGoogle Scholar
Mann, J. J., Stanley, M., McBride, P. A. & McEwen, B. S. (1986). Increase serotonin2 and β-adrenergic binding on frontal cortex of suicide victims. Archives of General Psychiatry 43, 954–959.CrossRefGoogle ScholarPubMed
Mann, J. J., Mahler, J. C., Wilner, P. J., Brown, R. P., Johnson, K. S., Kocsis, J. H. & Chen, J.-S. (1990). Normalisation of blunted lymphocyte β-adrenergic responsivity in melancholic inpatients by a course of electroconvulsive therapy. Archives of General Psychiatry 47, 461–464.CrossRefGoogle ScholarPubMed
Mitchell, P. B., Beam, J. A., Corn, T. H. & Checkley, S. A. (1988). Growth hormone response to clonidine after recovery in patients with endogenous depression. British Journal of Psychiatry 152, 34–38.CrossRefGoogle ScholarPubMed
Mullen, P. E., Linsell, C. R. & Parker, D. (1986). Influence of sleep disruption and calorie restriction on biological markers for depression. Lancet ii, 1051–1055.CrossRefGoogle Scholar
Naylor, G. J. & Smith, A. H. W. (1981). Defective genetic control of sodium pump density in manic depressive psychosis. Psychological Medicine 11, 257–263.CrossRefGoogle ScholarPubMed
Naylor, G. J., Dick, D. A. T., Dick, E. G., Le Poidevin, D. & Whyte, S. F. (1973). Erythrocyte membrane cation carrier in depressive illness. Psychological Medicine 3, 502–508.CrossRefGoogle ScholarPubMed
Naylor, G. J., Dick, D. A. T., Dick, E. G. & Moody, J. P. (1974 a). Lithium therapy and erythrocyte membrane cation carrier. Psychopharmacology 37, 81–86.CrossRefGoogle ScholarPubMed
Naylor, G. J., Dick, D. A. T., Dick, E. G., Worral, E. P., Peet, M., Dick, P. & Boardman, L. J. (1974 b). Erythrocyte membrane cation carrier in mania. Psychological Medicine 6, 659–663.CrossRefGoogle Scholar
Naylor, G. J., Smith, A. H. W., Boardman, L. J., Dick, D. A. T., Dick, E. G. & Dick, P. (1977). Lithium and erythrocyte membrane cation carrier studies in normal and manic depressive subjects. Psychological Medicine 7, 228–233.CrossRefGoogle ScholarPubMed
Nemeroff, C. B. (1988). The role of corticotropin-releasing factor in the pathogenesis of major depression. Pharmacopsychiatry 21, 76–82.CrossRefGoogle ScholarPubMed
Nemeroff, C. B., Owens, M. J., Bissette, G., Andorn, A. C. & Stanley, M. (1988). Reduced corticotropin releasing factor binding sites in the frontal cortex of suicide victims. Archives of General Psychiatry 45, 577–580.CrossRefGoogle ScholarPubMed
Nutt, D. J. (1989). Altered central α2-adrenoceptor sensitivity in panic disorder. Archives of General Psychiatry 46, 165–169.CrossRefGoogle Scholar
Pandey, G. N., Janicak, P. G. & Davis, J. M. (1987). Decreased beta-adrenergic receptors in the leucocytes of depressed patients. Psychiatry Research 22, 265–274.CrossRefGoogle ScholarPubMed
Pandey, G. N., Pandey, S. C., Janicak, P. G., Marks, R. C. & Davis, J. M. (1990). Serotonin-2 receptor binding sites in the platelets of depressed patients. Biological Psychiatry 28, 215–222.CrossRefGoogle Scholar
Reynolds, C. F. & Kupfer, D. J. (1987). Sleep research in affective illness. State of the art circa 1987. Sleep 10, 199–215.CrossRefGoogle ScholarPubMed
Rush, A. J., Erman, M. K., Giles, D. E., Schlesser, M. A., Carpenter, G., Vasavade, N. & Roffwang, H. P. (1986). Polysomnographic findings in recently drug-free and clinically remitted depressed patients. Archives of General Psychiatry 43, 199–215.CrossRefGoogle ScholarPubMed
Schittecatte, M., Charles, G., Machowski, R. & Wilmotte, J. (1989). Tricyclic wash-out and growth hormone response to clonidine. British Journal of Psychiatry 154, 850–863.CrossRefGoogle ScholarPubMed
Sedvall, G., Fande, L., Persson, A. & Wiesel, F.-A. (1986). Imaging of neurotransmitter receptors in the living human brain. Archives of General Psychiatry 43, 995–1005.CrossRefGoogle ScholarPubMed
Sengupta, N., Datta, S. C., Sengupta, D. & Bal, S. (1980). Platelet and erythrocyte membrane ATPase activity in depression and mania. Psychiatry Research 3, 337–344.CrossRefGoogle Scholar
Sharpley, A. L., Gregory, C. A., Solomon, R. A. & Cowen, P. J. (1990). Slow wave sleep and 5-HT2 receptor sensitivity during maintenance tricyclic antidepressant treatment. Journal of Affective Disorders 19, 273–277.CrossRefGoogle ScholarPubMed
Sneddon, J. M. (1973). Blood platelets as a model for monoamine containing neurones. Progress in Neurobiology 1, 151–187.CrossRefGoogle Scholar
Stein, M. B., Tancer, M. E. & Uhde, T. W. (1990). Major depression in patients with panic disorder: factors associated with course and compliance. Journal of Affective Disorders 19, 287–296.CrossRefGoogle Scholar
Upadhyaya, A. K., Pennell, I., Cowen, P. J. & Deakin, J. F. W. (1991). Blunted growth hormone and prolactin responses to L-tryptophan in depression: a state-dependent abnormality. Journal of Affective Disorders 21, 213–218.CrossRefGoogle ScholarPubMed
Wood, A. J. (1987). Changes in cation transport during affective illness. Do they have therapeutic implications? Human Psychopharmacology 2, 197–210.CrossRefGoogle Scholar
Wood, A. J., Aronson, J. K., Cowen, P. J. & Grahame-Smith, D. G. (1989 a). The measurement of transmembrane cation transport in vivo in acute manic illness. British Journal of Psychiatry 155, 501–504.CrossRefGoogle ScholarPubMed
Wood, A. J., Elphick, M., Aronson, J. K. & Grahame-Smith, D. G. (1989 b). The effect of lithium on cation transport measured in vivo in patients suffering from bipolar affective illness. British Journal of Psychiatry 155, 504–510.CrossRefGoogle ScholarPubMed
Wood, A. J., Viswalingam, A., Glue, P., Aronson, J. K. & Grahame-Smith, D. G. (1989 c). Measurement of cation transport in vivo in healthy volunteers after the oral administration of lithium carbonate. Clinical Science 76, 397–402.CrossRefGoogle ScholarPubMed
Wood, A. J., Smith, C. E., Clarke, E. E., Cowen, P. J., Aronson, J. K. & Grahame-Smith, D. G. (1991). Altered in vitro adaptive responses of lymphocyte Na+, K+-ATPase in patients with manic depressive psychosis. Journal of Affective Disorders 211, 99–206.Google Scholar
World Health Organization Collaborative Study (1990). Validity of imipramine platelet binding sites as a biological marker of endogenous depression. Pharmacopsychiatry 23, 113–117.CrossRefGoogle Scholar
Yates, M., Leake, A., Candy, J. M., Fairburn, A. F., McKeith, I. G. & Ferrier, I. N. (1990). 5-HT2 receptor changes in major depression. Biological Psychiatry 21, 489–496.CrossRefGoogle Scholar